Showing 461 - 480 results of 1,135 for search '"bone marrow"', query time: 0.05s Refine Results
  1. 461

    Hemophagocytic lymphohistiocytosis secondary to refractory acute myeloid leukemia resolved after second line treatment with azacitidine plus venetoclax by Claudio Fozza

    Published 2024-01-01
    “…The main clinical features of HLH are prolonged fever, hepatosplenomegaly, cytopenia, hypertriglyceridemia, hyperferritinemia and hemophagocytosis in bone marrow, liver, spleen or lymph nodes. Secondary HLH typically occurs in conjunction with severe infections, malignancies or autoimmune disorders and intensive chemotherapy, potentially complicating treatment of acute myeloid leukemia (AML) in around 10% of cases. …”
    Get full text
    Article
  2. 462

    A Unique Case of Relapsed B-Acute Lymphoblastic Leukemia/Lymphoma as an Isolated Omental Mass by Kanchan Kantekure, Furha Cossor, Kenneth B. Miller, Monika E. Pilichowska

    Published 2014-01-01
    “…We report an unusual case of B-ALL relapsing as an isolated omental mass along with bone marrow involvement.…”
    Get full text
    Article
  3. 463

    Acute Hematogenous Osteomyelitis in a Five-Month-Old Male with Rickets by Lucia J. Santiago, Minnie John, Maher Abulfaraj, Christabelle Co, Aseel Al-Jadiri

    Published 2017-01-01
    “…Osteomyelitis is defined as an infection of the bone, bone marrow, and the surrounding soft tissues. Most cases of acute hematogenous osteomyelitis in children are caused by Gram-positive bacteria, principally Staphylococcus aureus. …”
    Get full text
    Article
  4. 464

    Plasmablastic transformation of a double hit follicular lymphoma: An emerging entity by Shanaz Khodaiji, Vidisha Mahajan, Krishna Sawaimoon Satyakam, Pratibha Sudhan Kadam Amare

    Published 2024-04-01
    “…We report a case of simultaneous identification of extranodal, soft tissue plasmablastic lymphoma in the ankle and bone marrow involvement by follicular lymphoma. This unusual case presentation is a challenge for the treating physician with the patient becoming resistant to chemotherapy and succumbing to the disease within a few months of diagnosis. …”
    Get full text
    Article
  5. 465

    Diabetes, TZDs, and Bone: A Review of the Clinical Evidence by Ann V. Schwartz

    Published 2006-01-01
    “…Evidence from rodent and in vitro models suggests that activation of PPAR-γ by thiazolidinediones (TZDs) causes increased bone marrow adiposity and decreased osteoblastogenesis, resulting in bone loss. …”
    Get full text
    Article
  6. 466

    Effects of Isotretinoin on the Platelet Counts and the Mean Platelet Volume in Patients with Acne Vulgaris by Arzu Ataseven, Aynur Ugur Bilgin

    Published 2014-01-01
    “…Since the decrease of platelet counts and the mean platelet volume was seen concomitantly, it is concluded that the effect of isotretinoin was through the suppression of bone marrow.…”
    Get full text
    Article
  7. 467

    Oral Squamous Cell Carcinoma in a Patient with Fanconi Anemia by Milla Huuhka, Aaro Turunen

    Published 2021-01-01
    “…Fanconi anemia (FA) is a rare autosomal recessive genetic disorder characterized by different types of malformations, skin lesions, bone marrow failure, and increased risk for both hematological malignancies and solid tumors, especially head and neck squamous cell carcinomas (HNSCC). …”
    Get full text
    Article
  8. 468

    Dyspnea, Massive Effusion and Lytic Rib Lesion as Initial Presentation of Multiple Myeloma in a Young Man by Mohammed H AlShati, Ramesh Kumar, Shreeram Kannan

    Published 2013-01-01
    “…Multiple myeloma, a disorder commonly encountered in elderly patients, represents a malignant proliferation of plasma cells that primarily affects bone marrow. Pleural effusion as the presenting manifestation of the disease is uncommon. …”
    Get full text
    Article
  9. 469

    Dermatomyositis Associated with Myelofibrosis following Polycythemia Vera by Naomi Fei, Sarah Sofka

    Published 2017-01-01
    “…Due to persistent pancytopenia a bone marrow biopsy was performed and showed postpolycythemic myelofibrosis. …”
    Get full text
    Article
  10. 470

    Pleuroparenchymal Fibroelastosis as a Late-Onset Pulmonary Toxicity after Treatment with Anticancer Chemotherapy for High-Risk Neuroblastoma by Satoshi Yokoyama, Risa Kanai, Daisuke Fukao, Keigo Hamahata

    Published 2024-01-01
    “…In pediatrics, it has been described in patients with a history of malignancy who have received a bone marrow transplant, chemotherapy, or radiotherapy. …”
    Get full text
    Article
  11. 471

    Two Cases of Miliary Tuberculosis and Increasing Level of CA-125 by M Alimagham, S Aminiafshar, SMM H Moghaddam, S Shokuhi

    Published 2006-01-01
    “…Additionally, sometimes the serum level of CA 125 increases spontaneously during the menstrual cycle (8,9). In bone marrow transplantation, this marker is a sensitive index in the diagnosis of veno-occlusive disease (10). …”
    Get full text
    Article
  12. 472

    HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide by Andrea Bacigalupo, Simona Sica

    Published 2016-01-01
    “…PT-CY has been used following nonmyeloablative as well as myeloablative conditioning regimens, for bone marrow or peripheral blood grafts, for patients with malignant and nonmalignant disorders. …”
    Get full text
    Article
  13. 473

    Comparative analysis of propagation properties of ASFV Odintsvo 02/14 isolate in primary cell cultures by D. V. Sharypova, I. Yu. Zhukov, N. N. Vlasova, O. S. Puzankova, V. L. Gavrilova, A. S. Igolkin, N. V. Koropova, I. V. Zhbanova

    Published 2018-04-01
    “…The test results showed that the virus propagation was the most successful in porcine bone marrow and porcine kidney cells when fetal bovine serum and FS FetalClone II, multipurpose serum substitute were added.…”
    Get full text
    Article
  14. 474

    Correlation between Neutrophil Gelatinase Associated with Lipocaline and Beta-2 Microglobulin with Other Renal Markers in Iraqi Patients with Multiple Myeloma by Inas Nazeeh Abed, Usama Salman Al-timari, Hiba Abid Al-Hussein hassan, Abbas Thamer Dwayyikh

    Published 2022-11-01
    “… Multiple myeloma, often known as myeloma, is a kind of bone marrow cancer. The bone marrow is a spongy tissue in the middle of some bones that creates the body's blood cells. …”
    Get full text
    Article
  15. 475

    Ex Vivo Expansion of Murine MSC Impairs Transcription Factor-Induced Differentiation into Pancreatic β-Cells by Dario Gerace, Rosetta Martiniello-Wilks, Rosaline Habib, Binhai Ren, Najah Therese Nassif, Bronwyn Anne O’Brien, Ann Margaret Simpson

    Published 2019-01-01
    “…CD45-/Ly6+ murine MSCs were isolated from the bone marrow of nonobese diabetic (NOD) mice and nucleofected to express the bioluminescent protein, Firefly luciferase (Luc2). …”
    Get full text
    Article
  16. 476

    FoxA1 knockdown promotes BMSC osteogenesis in part by activating the ERK1/2 signaling pathway and preventing ovariectomy-induced bone loss by Lijun Li, Renjin Lin, Yang Xu, Lingdi Li, Zhijun Pan, Jian Huang

    Published 2025-02-01
    “…Using a mouse model in which the ovaries were surgically removed, researchers reported that suppressing the FOXA1 gene in bone marrow stem cells (BMSCs) prevented the loss of bone density caused by ovariectomy. …”
    Get full text
    Article
  17. 477
  18. 478

    Hypoxia-driven mobilization of altruistic cancer stem cells in platinum-treated head and neck cancer by Lekhika Pathak, Lekhika Pathak, Lekhika Pathak, Bidisha Pal, Bidisha Pal, Joyeeta Talukdar, Partha Jyoti Saikia, Sorra Sandhya, Wale Tasabehji, Wale Tasabehji, Hong Li, Jyotirmoy Phukan, Jyotirmoy Phukan, Anjan Bhuyan, Sanjukta Patra, Bikul Das, Bikul Das, Bikul Das, Bikul Das, Bikul Das

    Published 2025-02-01
    “…Our pre-clinical model confirmed that hypoxia directly correlates with the expansion of TSD+ CSCs and their mobilization into the circulation and bone marrow following cisplatin treatment. We demonstrated the protection of R-CSCs by TSD+ CSCs. …”
    Get full text
    Article
  19. 479
  20. 480

    Mesenchymal Progenitor Cells and Their Orthopedic Applications: Forging a Path towards Clinical Trials by Deana S. Shenaq, Farbod Rastegar, Djuro Petkovic, Bing-Qiang Zhang, Bai-Cheng He, Liang Chen, Guo-Wei Zuo, Qing Luo, Qiong Shi, Eric R. Wagner, Enyi Huang, Yanhong Gao, Jian-Li Gao, Stephanie H. Kim, Ke Yang, Yang Bi, Yuxi Su, Gaohui Zhu, Jinyong Luo, Xiaoji Luo, Jiaqiang Qin, Russell R. Reid, Hue H. Luu, Rex C. Haydon, Tong-Chuan He

    Published 2010-01-01
    “…While they can be isolated from various tissues, MPCs isolated from the bone marrow are best characterized. These cells represent a subset of bone marrow stromal cells (BMSCs) which, in addition to their differentiation potential, are critical in supporting proliferation and differentiation of hematopoietic cells. …”
    Get full text
    Article